Please Wait...

PSA // Prostate Specific Antigen

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Prostate Specific Antigen (PSA) is a member of the Kallikrein related peptidase and is also known as Kallikrein-Related peptidase 3 (KLK3). Its major physiological function is the liquefaction of seminal fluid through its proteolysis activity against gel proteins. PSA is normally found in seminal fluid and only a small proportion is found in blood. The release of PSA in blood circulation is believed to be the result of architecture modification and alterations in the basement membrane when prostate tumors develop (Lilja et al., 2008). In serum, PSA can be bound to α1-antichymotrypsin or α2-macroglobulin or can circulate as free PSA (mixture of mature and pro-, nicked and intact forms of free PSA). In addition to its diagnostic value, PSA levels in serum are measured to monitor treatment response and efficacy (Fleming et al., 2006).

Bioclinica Lab employs an automated sandwich chemiluminescent immunoassay for total PSA measurement in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (2 weeks ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (2 weeks ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (3 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (3 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (4 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (4 weeks ago)